One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection - 26/08/21
Doi : 10.1016/j.jinf.2021.06.016
Chloé Dimeglio a, b, ⁎ 
: Writing – original draftMethodologyFormal analysisData curationWriting – review & editing, Fabrice Herin c, d : Writing – original draftMethodologyData curationWriting – review & editing, Marcel Miedougé a : Writing – original draftMethodologyData curationWriting – review & editing, Isabelle Da-Silva a : Data curationWriting – review & editing, Marion Porcheron a : Data curationWriting – review & editing, Guillaume Martin-Blondel b, e : Writing – original draftMethodologyWriting – review & editing, Jean-Marc Soulat c, d : Writing – original draftMethodologyWriting – review & editing, Jacques Izopet a, b : Writing – original draftMethodologyData curationWriting – review & editing
: Writing – original draftMethodologyFormal analysisData curationWriting – review & editing, Fabrice Herin c, d : Writing – original draftMethodologyData curationWriting – review & editing, Marcel Miedougé a : Writing – original draftMethodologyData curationWriting – review & editing, Isabelle Da-Silva a : Data curationWriting – review & editing, Marion Porcheron a : Data curationWriting – review & editing, Guillaume Martin-Blondel b, e : Writing – original draftMethodologyWriting – review & editing, Jean-Marc Soulat c, d : Writing – original draftMethodologyWriting – review & editing, Jacques Izopet a, b : Writing – original draftMethodologyData curationWriting – review & editing a IFB, Laboratoire de Virologie, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, Toulouse 31300 France
b INSERM UMR 1291 – CNRS UMR 5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), Toulouse 31300, France
c Occupational Diseases Department, Toulouse-Purpan University Hospital, Toulouse 31000, France
d Centre for Epidemiology and Research in Population Health Unit (CERPOP), UMR1295, Unité Mixte INSERM - Université Toulouse III Paul Sabatier, Toulouse 31000, France
e Infectious and Tropical Diseases Department, Toulouse University Hospital, Toulouse 31300, France
⁎Corresponding author at: IFB, Laboratoire de Virologie, CHU Toulouse, Hôpital Purpan, 330 av de Grande Bretagne, Toulouse 31300 France.IFB, Laboratoire de VirologieCHU Toulouse, Hôpital Purpan330 av de Grande BretagneToulouse31300France
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : SARS-CoV-2, COVID-19, Healthcare workers, Vaccination, Neutralizing antibodies
Le texte complet de cet article est disponible en PDF.
© 2021
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 3
P. 381-412 - septembre 2021 Retour au numéro
Article précédent
- Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
- Marie Tré-Hardy, Roberto Cupaiolo, Alain Wilmet, Ingrid Beukinga, Laurent Blairon
- The surge in Covid related mucormycosis
- Somesh Chandra, Rakesh Rawal
Bienvenue sur EM-consulte, la référence des professionnels de santé.